Eva Ondroušková
Masaryk University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Eva Ondroušková.
Tumor Biology | 2016
Blanka Jančeková; Eva Ondroušková; Lucia Knopfová; Jan Šmarda; Petr Beneš
Cathepsin D (CD), a ubiquitously expressed lysosomal aspartic protease, is upregulated in human breast carcinoma and many other tumor types. CD has been repeatedly reported to act as key mediator of apoptosis induced by various chemotherapeutics. However, there is still controversy over the role of enzymatic/proteolytic versus protein-protein interaction activities of CD in apoptotic signaling. The elucidation of molecular mechanism responsible for the effect of CD in the chemotherapy-induced cell death is crucial for development of an appropriate strategy to target this protease in cancer treatment. Therefore, the objective of this study was to investigate the molecular mechanism behind the CD-mediated regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced cell death. For this purpose, MDA-MB-231 breast carcinoma cells with an increased level of wt CD (CD) or mutant enzymatically inactive CD (ΔCD) were subjected to TRAIL and the frequency of apoptosis was determined. Our results show that CD facilitates the TRAIL-induced apoptosis of MDA-MB-231 breast cancer cells in enzymatic activity-dependent manner. Moreover, the importance of endosomal/lysosomal acidification in this process was documented. Analysis of the potential substrates specifically cleaved by CD during the TRAIL-induced apoptosis confirmed caspase-8 and Bid proteins as the CD targets. Moreover, in search for protein regulators of apoptosis that can be cleaved by CD at physiologically relevant pH, we identified the Bcl-2 protein as a suitable candidate. The modulatory role of CD in cell response to TRAIL was also confirmed in another breast cancer cell line SKBR3. These experiments identified the CD enzymatic activity as a new factor affecting sensitivity of breast cancer cells to TRAIL.
Biological Chemistry | 2009
Eva Ondroušková; Jana Slováčková; Vendula Pelková; Jiřina Procházková; Karel Souček; Petr Beneš; Jan Šmarda
Abstract The Bcl-2 protein is one of the key components of biochemical pathways controlling programmed cell death. The function of this protein can be regulated by posttranslational modifications. Phosphorylation of Bcl-2 has been considered to be significantly associated with cell cycle arrest in the G2/M phase of the cell cycle, and with cell death caused by defects of microtubule dynamics. This study shows that phosphorylation of Bcl-2 can be induced by heavy metals due to activation of the Jun N-terminal kinase pathway that is not linked to the G2/M cell cycle arrest. Furthermore, we demonstrate that hyperphosphorylated Bcl-2 protein is a more potent inhibitor of zinc-induced cell death than its hypophosphorylated mutant form. These data suggest that regulation of Bcl-2 protein function by phosphorylation is an important part of cell responses to stress.
Leukemia Research | 2008
Eva Ondroušková; Karel Souček; Viktor Horváth; Jan Šmarda
Leukemia Research | 2007
Eva Ondroušková; Karolína Povolná; Petr Váňa; Petr Beneš; Hana Konečná; Zbyněk Zdráhal; Jan Šmarda
Archive | 2015
Blanka Jančeková; Petr Beneš; Eva Ondroušková; Lucia Knopfová; Jan Šmarda
Archive | 2014
Blanka Jančeková; Petr Beneš; Lucia Knopfová; Eva Ondroušková; Jan Šmarda
Klinická onkologie : casopis Ceské a Slovenské onkologické#N#spolecnosti. | 2014
Lucie Pekarčíková; Lucia Knopfová; Eva Ondroušková; Jan Šmarda
Klinická onkologie | 2014
Lucie Pekarčíková; Lucia Knopfová; Eva Ondroušková; Jan Šmarda
Klinická onkologie : casopis Ceské a Slovenské onkologické spolecnosti | 2014
Lucie Pekarčíková; Lucia Knopfová; Eva Ondroušková; Jan Šmarda
Archive | 2013
Blanka Jančeková; Eva Ondroušková; Lucia Knopfová; Petr Beneš; Jan Šmarda